Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors

Ingrid T. G. W. Bijsmans, Kim M. Smits, Pauline de Graeff, G. Bea A. Wisman, Ate G. J. van der Zee, Brigitte F. Slangen, Adriaan P. de Bruine, Manon van Engeland, Nathalie L. Sieben, Koen K. Van de Vijver

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)463-470
JournalModern Pathology
Volume24
Issue number3
DOIs
Publication statusPublished - Mar 2011

Keywords

  • immunohistochemistry
  • PCI
  • serous borderline tumor
  • serous ovarian carcinoma
  • SerpinA5
  • tissue microarray

Cite this

Bijsmans, I. T. G. W., Smits, K. M., de Graeff, P., Wisman, G. B. A., van der Zee, A. G. J., Slangen, B. F., de Bruine, A. P., van Engeland, M., Sieben, N. L., & Van de Vijver, K. K. (2011). Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. Modern Pathology, 24(3), 463-470. https://doi.org/10.1038/modpathol.2010.214